Company Overview

Pazoo, Inc. (OTC Pink: PZOO) is a micro-cap public company that historically operated in the health, wellness, and consumer information sectors, with later strategic involvement in cannabis-related testing and media activities. Public filings and OTC market disclosures indicate that the company focused on providing online health and wellness content, product marketing, and cannabis industry services through affiliated entities and partnerships. Over time, its business emphasis shifted toward cannabis testing laboratory operations and related industry infrastructure during periods of expanding state-level legalization in the United States.

The company’s reported business model evolved through acquisitions, licensing arrangements, and investments tied to cannabis compliance and consumer safety initiatives. Historically referenced revenue drivers included advertising, product promotion, and interests connected to cannabis laboratory operations. Publicly available disclosures suggest that Pazoo, Inc. sought to position itself around regulated cannabis testing and consumer transparency; however, the scale and continuity of these operations are difficult to independently verify from recent public reporting. Data inconclusive based on available public sources regarding the company’s current operating status and active revenue generation.

Business Operations

Historically, Pazoo, Inc. reported operations tied to online wellness platforms and later cannabis industry services. Public disclosures referenced involvement with MA & Associates, LLC, a Nevada-based cannabis testing laboratory operation that became central to the company’s strategic direction during the mid-2010s. The laboratory business was associated with cannabis product testing, regulatory compliance services, and analytical screening for contaminants and potency within legalized cannabis markets. The company also referenced media and consumer engagement initiatives tied to health and wellness information distribution.

Operations appeared concentrated primarily within the United States, particularly in states with legalized cannabis frameworks. Public information indicates that the company relied heavily on partnerships, licensing structures, and affiliated entities rather than large-scale proprietary infrastructure. Available filings and OTC disclosures do not provide clear evidence of significant international operations or diversified business segments in recent years. Data inconclusive based on available public sources regarding the extent of current active subsidiaries, operational laboratories, or ongoing commercial partnerships.

Strategic Position & Investments

The company’s strategic direction historically centered on gaining exposure to the regulated cannabis sector, particularly through compliance-driven testing services and cannabis safety verification. Public announcements and filings referenced investments and operational relationships involving MA & Associates, LLC, which was presented as a significant strategic asset due to increasing regulatory scrutiny in legalized cannabis markets. The company also explored broader cannabis-related branding and media opportunities during periods of heightened investor interest in the sector.

Unlike larger vertically integrated cannabis operators, Pazoo, Inc. appeared to pursue a niche positioning around testing, transparency, and ancillary services rather than direct cultivation or retail distribution. Available records do not indicate major large-scale acquisitions, institutional investment activity, or extensive capital deployment comparable to established public cannabis companies. Recent independently verifiable information regarding active investment programs, emerging technology initiatives, or current strategic expansion plans remains limited. Data inconclusive based on available public sources.

Geographic Footprint

Public disclosures indicate that Pazoo, Inc. maintained its headquarters in the United States, with operational emphasis connected primarily to the Nevada cannabis market through affiliated laboratory activities. The company’s historical activities and investor communications focused largely on domestic opportunities linked to evolving U.S. cannabis legalization trends rather than broad multinational expansion.

There is limited verifiable evidence of meaningful operational presence outside the United States. While the company’s online wellness and informational activities were internet-accessible, available public filings do not demonstrate substantial international infrastructure, overseas subsidiaries, or material foreign revenue exposure. The company’s operational footprint appears to have remained concentrated in select U.S. jurisdictions tied to cannabis regulation and ancillary services.

Leadership & Governance

Publicly available records indicate multiple leadership changes over the company’s history, though recent governance information is limited and in some cases outdated across available market databases and filings. Historically, company leadership emphasized participation in emerging regulated cannabis markets, particularly through compliance and laboratory testing infrastructure. Due to inconsistent and limited recent disclosures, some executive and governance information cannot be independently confirmed from current filings.

Key executives and officers identified in historical public disclosures include:

• David Cunic – Chief Executive Officer
• Steve Basloe – President
• Richard A. Goulding – Former executive leadership and board involvement

Available governance information suggests that management’s strategic vision focused on leveraging regulatory trends in legalized cannabis markets while attempting to build ancillary service capabilities tied to testing and consumer safety. However, the company’s recent reporting frequency and operational transparency appear limited relative to fully reporting public companies.